减重手术全球基准值的定义:微创Roux-en-Y胃旁路术与袖状胃切除术的多中心回顾性分析
该研究基于3大洲19家高容量学术中心2012年6月至2017年5月间39424例择期减重手术,筛选出4120例RYGB与1457例SG低危病例,以各中心中位值的第75百分位定义基准值。90天内RYGB与SG分别有7.2%与6.2%患者出现至少1种并发症,无死亡;两类手术90天基准值均为Clavien-Dindo≥IIIa级并发症率5.5%、再入院率5.5%、综合并发症指数≤33.73。
要点
- 低危减重手术90天基准值为≥IIIa级并发症率5.5%、再入院率5.5%
- RYGB与SG低危患者90天内无死亡,非基准病例死亡率为0.06%
- 再入院最常见原因为症状性胆石症与不明原因腹痛
核心结论
- 以各中心中位值的第75百分位定义减重手术围术期结局基准值,可作为手术质量指标并用于质量改进循环。
研究设计与样本
- 多中心回顾性分析,来自3大洲19家高容量学术中心2012年6月至2017年5月的39424例择期减重手术。
- 低危病例定义为无既往腹部手术、无同期联合手术、无糖尿病、睡眠呼吸暂停、心脏病、肾功能不全、炎症性肠病、免疫抑制、抗凝、BMI>50 kg/m及年龄>65岁。
- 共纳入4120例RYGB与1457例SG低危病例,并发症按综合并发症指数分级,基准值取各中心中位值的第75百分位。
主要发现
- 患者以女性为主(78%),年龄38±11岁,基线BMI 40.8±5.8 kg/m。
- 90天内7.2%的RYGB与6.2%的SG患者出现至少1种并发症,无患者死亡;非基准病例死亡率为0.06%。
- 两种手术后90天再入院最常见原因为症状性胆石症与不明原因腹痛。
关键数值与推荐
- RYGB与SG术后90天基准值:Clavien-Dindo≥IIIa级并发症率5.5%。
- RYGB与SG术后90天基准值:再入院率5.5%。
- 出现至少1种≥II级并发症的患者亚组中,综合并发症指数基准值为≤33.73。
临床怎么用
- 可将上述基准值用于减重手术中心间的围术期结局比较与质量改进循环。
- 比较结局时需按研究定义的低危标准校正病例组合异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To define "best possible" outcomes for bariatric surgery (BS)(Roux-en-Y gastric bypass [RYGB] and sleeve gastrectomy [SG]). BACKGROUND: Reference values for optimal surgical outcomes in well-defined low-risk bariatric patients have not been established so far. Consequently, outcome comparison across centers and over time is impeded by heterogeneity in case-mix. METHODS: Out of 39,424 elective BS performed in 19 high-volume academic centers from 3 continents between June 2012 and May 2017, we identified 4120 RYGB and 1457 SG low-risk cases defined by absence of previous abdominal surgery, concomitant procedures, diabetes mellitus, sleep apnea, cardiopathy, renal insufficiency, inflammatory bowel disease, immunosuppression, anticoagulation, BMI>50 kg/m and age>65 years. We chose clinically relevant endpoints covering the intra- and postoperative course. Complications were graded by severity using the comprehensive complication index. Benchmark values were defined as the 75th percentile of the participating centers' median values for respective quality indicators. RESULTS: Patients were mainly females (78%), aged 38±11 years, with a baseline BMI 40.8 ± 5.8 kg/m. Over 90 days, 7.2% of RYGB and 6.2% of SG patients presented at least 1 complication and no patients died (mortality in nonbenchmark cases: 0.06%). The most frequent reasons for readmission after 90-days following both procedures were symptomatic cholelithiasis and abdominal pain of unknown origin. Benchmark values for both RYGB and SG at 90-days postoperatively were 5.5% Clavien-Dindo grade ≥IIIa complication rate, 5.5% readmission rate, and comprehensive complication index ≤33.73 in the subgroup of patients presenting at least 1 grade ≥II complication. CONCLUSION: Benchmark cutoffs targeting perioperative outcomes in BS offer a new tool in surgical quality-metrics and may be implemented in quality-improvement cycle.ClinicalTrials.gov Identifier NCT03440138.
引用
- Gero D, Raptis DA, Vleeschouwers W, et al. Defining Global Benchmarks in Bariatric Surgery: A Retrospective Multicenter Analysis of Minimally Invasive Roux-en-Y Gastric Bypass and Sleeve Gastrectomy. Ann Surg. 2019. PMID: 31592894. doi:10.1097/SLA.0000000000003512
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。